Stocks and Investing Stocks and Investing
Thu, September 1, 2022
[ 12:00 AM ] - WOPRAI
Patrick Ho Maintained (STX) at Strong Buy with Decreased Target to $97 on, Sep 1st, 2022
[ 12:00 AM ] - WOPRAI
Gus Richard Maintained (STX) at Buy with Decreased Target to $88 on, Sep 1st, 2022
[ 12:00 AM ] - WOPRAI
Joshua Pokrzywinski Maintained (CARR) at Buy with Increased Target to $44 on, Sep 1st, 2022
[ 12:00 AM ] - WOPRAI
Steven Enders Initiated (BOX) at Strong Buy and Held Target at $34 on, Sep 1st, 2022
[ 12:00 AM ] - WOPRAI
Steven Enders Initiated (BL) at Hold and Held Target at $73 on, Sep 1st, 2022
[ 12:00 AM ] - WOPRAI
Steven Seedhouse Initiated (ANAB) at Buy and Held Target at $35 on, Sep 1st, 2022
[ 12:00 AM ] - WOPRAI
Steven Enders Initiated (ASAN) at Hold and Held Target at $23 on, Sep 1st, 2022
[ 12:00 AM ] - WOPRAI
Steven Enders Initiated (APPN) at Hold and Held Target at $55 on, Sep 1st, 2022
[ 12:00 AM ] - WOPRAI
Steven Enders Initiated (WK) at Strong Buy and Held Target at $86 on, Sep 1st, 2022
[ 12:00 AM ] - WOPRAI
Mark Miller Downgraded (WDC) to Strong Sell and Held Target at $34 on, Sep 1st, 2022
[ 12:00 AM ] - WOPRAI
Steven Enders Initiated (WDAY) at Hold and Held Target at $186 on, Sep 1st, 2022
Wed, August 31, 2022
[ 12:00 AM ] - WOPRAI
Dana Telsey Maintained (AEO) at Hold with Decreased Target to $15 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Ronald Kamdem Initiated (WELL) at Buy and Held Target at $90 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Heiko Ihle Maintained (WRN) at Strong Buy with Decreased Target to $2.5 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Benjamin Budish Initiated (ARES) at Buy and Held Target at $92 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Benjamin Budish Initiated (APO) at Buy and Held Target at $70 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Joshua Chan Maintained (AMWD) at Hold with Increased Target to $58 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Jeanine Wai Maintained (APA) at Buy with Decreased Target to $53 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Paul Lejuez Maintained (ANF) at Hold with Decreased Target to $19 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Roger Song Maintained (ALT) at Strong Buy with Increased Target to $35 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
John Vinh Maintained (AMBA) at Buy with Decreased Target to $100 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Kevin Cassidy Maintained (AMBA) at Strong Buy with Decreased Target to $110 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Gary Mobley Maintained (AMBA) at Buy with Decreased Target to $105 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Tristan Gerra Maintained (AMBA) at Buy with Decreased Target to $90 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Kinngai Chan Downgraded (AMBA) to Hold on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Tore Svanberg Maintained (AMBA) at Strong Buy with Decreased Target to $94 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Benjamin Budish Maintained (BX) at Buy and Held Target at $120 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Kaveri Pohlman Initiated (STTK) at Strong Buy and Held Target at $12 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
Jeanine Wai Maintained (STR) at Buy with Decreased Target to $34 on, Aug 31st, 2022
[ 12:00 AM ] - WOPRAI
David Amsellem Maintained (SUPN) at Buy with Increased Target to $38 on, Aug 31st, 2022

David Amsellem Maintained (SUPN) at Buy with Increased Target to $38 on, Aug 31st, 2022


Published on 2024-10-27 22:52:22 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Maintained "Supernus Pharmaceuticals, Inc." (SUPN) at Buy with Increased Target from $33 to $38 on, Aug 31st, 2022.

David, nor any peers, have made any analyst calls on SUPN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources